CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
The plant is currently scaling towards a production capacity of nearly 3 million gloves per day
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
Move comes amid rising regulatory pressures
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Pharma giant targets new standards of care
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Subscribe To Our Newsletter & Stay Updated
